Single-cell RNA sequencing reveals distinct cellular factors for response to immunotherapy targeting CD73 and PD-1 in colorectal cancer
Background Although cancer immunotherapy is one of the most effective advanced-stage cancer therapies, no clinically approved cancer immunotherapies currently exist for colorectal cancer (CRC). Recently, programmed cell death protein 1 (PD-1) blockade has exhibited clinical benefits according to ong...
Main Authors: | Miok Kim, Yong Ki Min, Jinho Jang, Hyejin Park, Semin Lee, Chang Hoon Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2021-07-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/9/7/e002503.full |
Similar Items
-
CD73's Potential as an Immunotherapy Target in Gastrointestinal Cancers
by: Jerry B. Harvey, et al.
Published: (2020-04-01) -
Prognostic value of CD73 expression in resected colorectal cancer liver metastasis
by: Nouredin Messaoudi, et al.
Published: (2020-01-01) -
p73 in colorectal cancer
by: Pfeifer, Daniella
Published: (2009) -
Tumor Infiltration with CD20+CD73+ B Cells Correlates with Better Outcome in Colorectal Cancer
by: Bénard, A., et al.
Published: (2022) -
Cellular immunotherapy in multiple myeloma
by: Manh-Cuong Vo, et al.
Published: (2019-09-01)